Angela A. Armstrong

Array ( [id] => 8990344 [patent_doc_number] => 20130217625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'COMPOSITIONS AND METHODS FOR PRODUCING BIOACTIVE FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/861348 [patent_app_country] => US [patent_app_date] => 2013-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 37798 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13861348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10233189 [patent_doc_number] => 20150118184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-30 [patent_title] => 'ANTI-LAMP5 ANTIBODY AND UTILIZATION THEREOF' [patent_app_type] => utility [patent_app_number] => 14/388649 [patent_app_country] => US [patent_app_date] => 2013-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 29109 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11582927 [patent_doc_number] => 09637553 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-02 [patent_title] => 'Anti-sPLA2-IIA antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/387430 [patent_app_country] => US [patent_app_date] => 2013-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15818 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14387430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9895091 [patent_doc_number] => 20150050290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-19 [patent_title] => 'Method and Pharmaceutical Composition for use in the Treatment or the Prevention of Aneurysm' [patent_app_type] => utility [patent_app_number] => 14/386250 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5024 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14386250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11767918 [patent_doc_number] => 09376494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-28 [patent_title] => 'Antibodies to kallidin and des-Arg9-kallidin' [patent_app_type] => utility [patent_app_number] => 14/382798 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 32973 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14382798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8964088 [patent_doc_number] => 20130203690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-08 [patent_title] => 'PDE III INHIBITORS FOR TREATMENT OF ASYMPTOMATIC HEART FAILURE' [patent_app_type] => utility [patent_app_number] => 13/832292 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6164 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13832292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9857332 [patent_doc_number] => 20150037350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'NEGATIVE MODULATOR OF HEDGEHOG SIGNALLING FOR USE IN TREATING TH2-MEDIATED DISEASES' [patent_app_type] => utility [patent_app_number] => 14/385251 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12254 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14385251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12428364 [patent_doc_number] => 09975962 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-22 [patent_title] => Thrombin/plasmin-regulated antibodies that bind TFPI [patent_app_type] => utility [patent_app_number] => 14/389219 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4996 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9263206 [patent_doc_number] => 20130345135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'INHIBITION OF MYPB-C BINDING TO MYOSIN AS A TREATMENT FOR HEART FAILURE' [patent_app_type] => utility [patent_app_number] => 13/827023 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17862 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13827023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9895041 [patent_doc_number] => 20150050240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-19 [patent_title] => 'TREATMENT OF FIBROSIS' [patent_app_type] => utility [patent_app_number] => 14/388091 [patent_app_country] => US [patent_app_date] => 2013-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14616 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9041144 [patent_doc_number] => 20130243782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'HYPOXIA-INDUCED MITOGENIC FACTOR' [patent_app_type] => utility [patent_app_number] => 13/793354 [patent_app_country] => US [patent_app_date] => 2013-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7996 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13793354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8990346 [patent_doc_number] => 20130217627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'THERAPEUTIC APPLICATION OF ADIPONECTIN IN PATIENTS WITH VENTRICULAR FIBRILLATION' [patent_app_type] => utility [patent_app_number] => 13/793931 [patent_app_country] => US [patent_app_date] => 2013-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3992 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13793931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9864207 [patent_doc_number] => 20150044227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-12 [patent_title] => 'METHODS OF TREATMENT WITH ANGIOPOIETIN-2 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/383377 [patent_app_country] => US [patent_app_date] => 2013-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19026 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14383377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9839540 [patent_doc_number] => 20150031622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'RHOGEF12 IS A THERAPEUTIC TARGET FOR THE TREATMENT OF HEART FAILURE' [patent_app_type] => utility [patent_app_number] => 14/382094 [patent_app_country] => US [patent_app_date] => 2013-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20664 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14382094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9003099 [patent_doc_number] => 20130224224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'CX3CR1-BINDING POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/775307 [patent_app_country] => US [patent_app_date] => 2013-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37027 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13775307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10975624 [patent_doc_number] => 20140378659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'OXIDIZED LDL INHIBITOR' [patent_app_type] => utility [patent_app_number] => 14/376592 [patent_app_country] => US [patent_app_date] => 2013-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8415 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14376592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12193884 [patent_doc_number] => 09897607 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-20 [patent_title] => 'Methods, kits, and systems for treatment of metastatic papillary thyroid cancer' [patent_app_type] => utility [patent_app_number] => 14/376081 [patent_app_country] => US [patent_app_date] => 2013-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 15 [patent_no_of_words] => 16958 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14376081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10933090 [patent_doc_number] => 20140336111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-13 [patent_title] => 'Therapeutic Use of Activators of Zinc Finger Protein GL13' [patent_app_type] => utility [patent_app_number] => 14/374887 [patent_app_country] => US [patent_app_date] => 2013-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 6875 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14374887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8927560 [patent_doc_number] => 20130183320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'ANTI-LRP5 ANTIBODIES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/744766 [patent_app_country] => US [patent_app_date] => 2013-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 22438 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13744766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9107073 [patent_doc_number] => 20130280205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-24 [patent_title] => 'Activators of SGK-1 for Use as Cardioprotective Agents' [patent_app_type] => utility [patent_app_number] => 13/740889 [patent_app_country] => US [patent_app_date] => 2013-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8601 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13740889 [rel_patent_id] =>[rel_patent_doc_number] =>)